CAREER: Vascular Gene Therapy: Characterization and Optimization

职业:血管基因治疗:表征和优化

基本信息

项目摘要

9985012CheslerGene therapy is an exciting new modality for treating and preventing vascular disease. Engineered gene therapy delivery techniques could make this technology more affordable and thus broadly accessible to the cardiovascular patient population. By applying quantitative engineering analyses to a living, biological system, the PI hopes to further our knowledge of human vascular transport mechanisms (aim 1), optimize adenoviral gene therapy methods (aim 2), and assess the efficacy of optimized gene therapy treatment strategies in human arteries and veins (aim 3). An ex vivo vascular culture system will be used to pursue each of these goals. Ex vivo arterial and venous organ culture is an ideal experimental paradigm for investigating vascular transport phenomena under rigorous environmental and mechanical control. Further, it allows living human tissue experimentation in a three-dimensional, near-physiological environment. The first educational goal of the proposed career plan is to teach engineering students the fundamentals in the PI's area of specialization: the thermofluid sciences (aim 1). The techniques of problem-based learning and interaction with local industry will be used to achieve this goal. The second aim is to strengthen teamwork and communication skills in both graduate and undergraduate engineers (aim 2). Specifically, students will be given design projects in classes and assigned to mixed-level and mixed-gender teams. They will be given instruction in technical communication and practice by giving presentations to their peers and a lay audience (local middle-school children). The third goal of the educational program is to addresses the problem of diversity in the engineering workforce (aim 3). University-level mentoring will be frequent and informal. Through outreach and mentoring at the university, high school and middle school levels, the PI hopes to increase the number of women in engineering and in the pipeline.
9985012Chesler基因疗法是治疗和预防血管疾病的一种令人兴奋的新方式。工程基因治疗交付技术可以使这项技术更负担得起,从而广泛适用于心血管患者群体。通过将定量工程分析应用于活体生物系统,PI希望进一步了解人类血管转运机制(目标1),优化腺病毒基因治疗方法(目标2),并评估优化基因治疗策略在人类动脉和静脉中的疗效(目标3)。将使用离体血管培养系统来实现这些目标中的每一个。离体动脉和静脉器官培养是在严格的环境和机械控制下研究血管运输现象的理想实验范例。 此外,它允许在三维的、接近生理的环境中进行活体人体组织实验。拟议职业计划的第一个教育目标是向工程专业的学生传授PI专业领域的基础知识:热流体科学(目标1)。为实现这一目标,将采用以问题为基础的学习和与当地工业界互动的技术。第二个目标是加强研究生和本科生工程师的团队合作和沟通技巧(目标2)。 具体来说,学生将在课堂上获得设计项目,并分配到混合级别和混合性别的团队。他们将通过向同龄人和非专业观众(当地中学生)进行演示来获得技术交流和实践方面的指导。教育计划的第三个目标是解决工程劳动力的多样性问题(目标3)。大学一级的辅导将是经常和非正式的。 通过在大学、高中和初中一级的推广和指导,PI希望增加工程和管道中的妇女人数。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Naomi Chesler其他文献

Improvement in pulmonary hypertension discrimination using multiple MRA pant-leg parameters of pulmonary artery
  • DOI:
    10.1186/1532-429x-16-s1-o73
  • 发表时间:
    2014-01-16
  • 期刊:
  • 影响因子:
  • 作者:
    Phillip Kilgas;Eric M Schrauben;Alejandro Roldán-Alzate;Naomi Chesler;Oliver Wieben;Christopher J Francois;Mark L Schiebler
  • 通讯作者:
    Mark L Schiebler
In-vivo and Ex-vivo Characterization of Estrogen Receptor α (ERα)-Mediated Effects on the Pulmonary Vasculature in PH
  • DOI:
    10.1016/j.jamcollsurg.2021.07.063
  • 发表时间:
    2021-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Betty J. Allen;Rasika Ramanathan;Hailey Frye;Timothy A. Hacker;Tim Lahm;Naomi Chesler
  • 通讯作者:
    Naomi Chesler

Naomi Chesler的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Naomi Chesler', 18)}}的其他基金

Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244996
  • 财政年份:
    2023
  • 资助金额:
    $ 20.01万
  • 项目类别:
    Standard Grant
TUES-Type 2: First-year Virtual Internships to Increase Persistence of Underrepresented Groups in Engineering: RescuShell and its Parent Company RescuTek
TUES-Type 2:第一年虚拟实习,以提高工程领域代表性不足群体的持久性:RescuShell 及其母公司 RescuTek
  • 批准号:
    1225885
  • 财政年份:
    2012
  • 资助金额:
    $ 20.01万
  • 项目类别:
    Standard Grant
CAREER: Vascular Gene Therapy: Characterization and Optimization
职业:血管基因治疗:表征和优化
  • 批准号:
    0234007
  • 财政年份:
    2002
  • 资助金额:
    $ 20.01万
  • 项目类别:
    Standard Grant
Summer Institute in Japan for U.S. Graduate Students in Science and Engineering
美国科学与工程研究生日本暑期学院
  • 批准号:
    9213261
  • 财政年份:
    1992
  • 资助金额:
    $ 20.01万
  • 项目类别:
    Standard Grant

相似海外基金

Effects of Mechanical Stress and Phenotype Switching on Human Stem Cell-Derived Vascular Smooth Muscle Cells: Modeling Gene Regulatory Networks
机械应力和表型转换对人类干细胞衍生的血管平滑肌细胞的影响:基因调控网络建模
  • 批准号:
    2135907
  • 财政年份:
    2022
  • 资助金额:
    $ 20.01万
  • 项目类别:
    Standard Grant
Investigation of the effect of the clock gene Bmal1 on vascular endothelial glycocalyx synthesis.
研究时钟基因 Bmal1 对血管内皮糖萼合成的影响。
  • 批准号:
    22K16624
  • 财政年份:
    2022
  • 资助金额:
    $ 20.01万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Novel Gene Therapy for Critical Limb Ischemia and Limb Salvage in Vascular Occlusive Disease
针对血管闭塞性疾病严重肢体缺血和保肢的新型基因疗法
  • 批准号:
    10722862
  • 财政年份:
    2022
  • 资助金额:
    $ 20.01万
  • 项目类别:
Novel Gene Therapy for Critical Limb Ischemia and Limb Salvage in Vascular Occlusive Disease
针对血管闭塞性疾病严重肢体缺血和保肢的新型基因疗法
  • 批准号:
    10447520
  • 财政年份:
    2022
  • 资助金额:
    $ 20.01万
  • 项目类别:
Analyzing the Endothelial Cell-Expressed Prion Gene Prnd in Vascular Development
血管发育中内皮细胞表达的朊病毒基因 Prnd 的分析
  • 批准号:
    10532771
  • 财政年份:
    2021
  • 资助金额:
    $ 20.01万
  • 项目类别:
Epigenetic Control of Endothelial Gene Expression and Vascular Development
内皮基因表达和血管发育的表观遗传控制
  • 批准号:
    RGPIN-2016-05578
  • 财政年份:
    2021
  • 资助金额:
    $ 20.01万
  • 项目类别:
    Discovery Grants Program - Individual
ADAMTS13 gene polymorphism genome editing creation of vascular endothelial cells and exploration for new leukemia therapies
ADAMTS13基因多态性基因组编辑血管内皮​​细胞创建及白血病新疗法探索
  • 批准号:
    21K08427
  • 财政年份:
    2021
  • 资助金额:
    $ 20.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analyzing the Endothelial Cell-Expressed Prion Gene Prnd in Vascular Development
血管发育中内皮细胞表达的朊病毒基因 Prnd 的分析
  • 批准号:
    10388824
  • 财政年份:
    2021
  • 资助金额:
    $ 20.01万
  • 项目类别:
Analysis of novel vascular malformation causative gene
新型血管畸形致病基因分析
  • 批准号:
    21H03041
  • 财政年份:
    2021
  • 资助金额:
    $ 20.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Regulatory mechanisms of gene expression linking impaired vascular health with preeclamptic pregnancies
将血管健康受损与先兆子痫妊娠联系起来的基因表达调节机制
  • 批准号:
    448634553
  • 财政年份:
    2020
  • 资助金额:
    $ 20.01万
  • 项目类别:
    Research Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了